344 related articles for article (PubMed ID: 31667064)
1. Radiomics signature extracted from diffusion-weighted magnetic resonance imaging predicts outcomes in osteosarcoma.
Zhao S; Su Y; Duan J; Qiu Q; Ge X; Wang A; Yin Y
J Bone Oncol; 2019 Dec; 19():100263. PubMed ID: 31667064
[TBL] [Abstract][Full Text] [Related]
2. An MRI-based radiomics signature and clinical characteristics for survival prediction in early-stage cervical cancer.
Zheng RR; Cai MT; Lan L; Huang XW; Yang YJ; Powell M; Lin F
Br J Radiol; 2022 Jan; 95(1129):20210838. PubMed ID: 34797703
[TBL] [Abstract][Full Text] [Related]
3. Improving survival prediction of high-grade glioma via machine learning techniques based on MRI radiomic, genetic and clinical risk factors.
Tan Y; Mu W; Wang XC; Yang GQ; Gillies RJ; Zhang H
Eur J Radiol; 2019 Nov; 120():108609. PubMed ID: 31606714
[TBL] [Abstract][Full Text] [Related]
4. Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer.
Huang Y; Liu Z; He L; Chen X; Pan D; Ma Z; Liang C; Tian J; Liang C
Radiology; 2016 Dec; 281(3):947-957. PubMed ID: 27347764
[TBL] [Abstract][Full Text] [Related]
5. Radiomics Profiling Identifies the Incremental Value of MRI Features beyond Key Molecular Biomarkers for the Risk Stratification of High-Grade Gliomas.
Yang G; Sha Y; Wang X; Tan Y; Zhang H
Contrast Media Mol Imaging; 2022; 2022():8952357. PubMed ID: 35386727
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric MRI-Based Radiomic Signature for Preoperative Evaluation of Overall Survival in Intrahepatic Cholangiocarcinoma After Partial Hepatectomy.
Yang Y; Zou X; Zhou W; Yuan G; Hu D; Kuang D; Shen Y; Xie Q; Zhang Q; Hu X; Li Z
J Magn Reson Imaging; 2022 Sep; 56(3):739-751. PubMed ID: 35049076
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Lymph Node Metastasis in Advanced Gastric Cancer Using Magnetic Resonance Imaging-Based Radiomics.
Chen W; Wang S; Dong D; Gao X; Zhou K; Li J; Lv B; Li H; Wu X; Fang M; Tian J; Xu M
Front Oncol; 2019; 9():1265. PubMed ID: 31824847
[No Abstract] [Full Text] [Related]
8. Dual-region radiomics signature: Integrating primary tumor and lymph node computed tomography features improves survival prediction in esophageal squamous cell cancer.
Lu N; Zhang WJ; Dong L; Chen JY; Zhu YL; Zhang SH; Fu JH; Yin SH; Li ZC; Xie CM
Comput Methods Programs Biomed; 2021 Sep; 208():106287. PubMed ID: 34311416
[TBL] [Abstract][Full Text] [Related]
9. Prediction of response to preoperative neoadjuvant chemotherapy in extremity high-grade osteosarcoma using X-ray and multiparametric MRI radiomics.
Luo Z; Li J; Liao Y; Huang W; Li Y; Shen X
J Xray Sci Technol; 2023; 31(3):611-626. PubMed ID: 37005907
[TBL] [Abstract][Full Text] [Related]
10. Development and external validation of an MRI-based radiomics nomogram for pretreatment prediction for early relapse in osteosarcoma: A retrospective multicenter study.
Chen H; Liu J; Cheng Z; Lu X; Wang X; Lu M; Li S; Xiang Z; Zhou Q; Liu Z; Zhao Y
Eur J Radiol; 2020 Aug; 129():109066. PubMed ID: 32502729
[TBL] [Abstract][Full Text] [Related]
11. Advanced zoomed diffusion-weighted imaging vs. full-field-of-view diffusion-weighted imaging in prostate cancer detection: a radiomic features study.
Hu L; Zhou DW; Fu CX; Benkert T; Jiang CY; Li RT; Wei LM; Zhao JG
Eur Radiol; 2021 Mar; 31(3):1760-1769. PubMed ID: 32935192
[TBL] [Abstract][Full Text] [Related]
12. MRI-based radiomics signature for pretreatment prediction of pathological response to neoadjuvant chemotherapy in osteosarcoma: a multicenter study.
Chen H; Zhang X; Wang X; Quan X; Deng Y; Lu M; Wei Q; Ye Q; Zhou Q; Xiang Z; Liang C; Yang W; Zhao Y
Eur Radiol; 2021 Oct; 31(10):7913-7924. PubMed ID: 33825032
[TBL] [Abstract][Full Text] [Related]
13. Radiomics Analysis Based on Magnetic Resonance Imaging for Preoperative Overall Survival Prediction in Isocitrate Dehydrogenase Wild-Type Glioblastoma.
Wang S; Xiao F; Sun W; Yang C; Ma C; Huang Y; Xu D; Li L; Chen J; Li H; Xu H
Front Neurosci; 2021; 15():791776. PubMed ID: 35153659
[TBL] [Abstract][Full Text] [Related]
14. Preoperative Assessment for Event-Free Survival With Hepatoblastoma in Pediatric Patients by Developing a CT-Based Radiomics Model.
Jiang Y; Sun J; Xia Y; Cheng Y; Xie L; Guo X; Guo Y
Front Oncol; 2021; 11():644994. PubMed ID: 33937051
[No Abstract] [Full Text] [Related]
15. MRI Radiomics Signature of Pediatric Medulloblastoma Improves Risk Stratification Beyond Clinical and Conventional MR Imaging Features.
Zheng H; Li J; Liu H; Ting G; Yin Q; Li R; Liu M; Zhang Y; Duan S; Li Y; Wang D
J Magn Reson Imaging; 2023 Jul; 58(1):236-246. PubMed ID: 36412264
[TBL] [Abstract][Full Text] [Related]
16. DWI-based radiomic signature: potential role for individualized adjuvant chemotherapy in intrahepatic cholangiocarcinoma after partial hepatectomy.
Yang Y; Zou X; Zhou W; Yuan G; Hu D; Shen Y; Xie Q; Zhang Q; Kuang D; Hu X; Li Z
Insights Imaging; 2022 Mar; 13(1):37. PubMed ID: 35244793
[TBL] [Abstract][Full Text] [Related]
17. A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation.
Fang S; Lai L; Zhu J; Zheng L; Xu Y; Chen W; Wu F; Wu X; Chen M; Weng Q; Ji J; Zhao Z; Tu J
Front Mol Biosci; 2021; 8():662366. PubMed ID: 34532340
[No Abstract] [Full Text] [Related]
18. Novel Non-Invasive Radiomic Signature on CT Scans Predicts Response to Platinum-Based Chemotherapy and Is Prognostic of Overall Survival in Small Cell Lung Cancer.
Jain P; Khorrami M; Gupta A; Rajiah P; Bera K; Viswanathan VS; Fu P; Dowlati A; Madabhushi A
Front Oncol; 2021; 11():744724. PubMed ID: 34745966
[TBL] [Abstract][Full Text] [Related]
19. Radiomics study for predicting the expression of PD-L1 in non-small cell lung cancer based on CT images and clinicopathologic features.
Sun Z; Hu S; Ge Y; Wang J; Duan S; Song J; Hu C; Li Y
J Xray Sci Technol; 2020; 28(3):449-459. PubMed ID: 32176676
[TBL] [Abstract][Full Text] [Related]
20. Multiparametric magnetic resonance imaging-derived radiomics for the prediction of disease-free survival in early-stage squamous cervical cancer.
Zhou Y; Gu HL; Zhang XL; Tian ZF; Xu XQ; Tang WW
Eur Radiol; 2022 Apr; 32(4):2540-2551. PubMed ID: 34642807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
